Psoriasis: Risankizumab versus Ustekinumab in der Langzeitanalyse • MedWiss.Online

Original Titel:
Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post hoc…

Quelle: MedWiss.de

Schreibe einen Kommentar